BOSTON--(BUSINESS WIRE)--CLEW, a clinical intelligence and predictive surveillance company, today announced the general availability of its FDA-cleared, AI-driven, intelligent clinical surveillance platform. Built upon proprietary, machine-learning derived prediction models and rules-based best practices, the CLEW platform offers health systems an early identification of a patient’s risk of deterioration..

波士顿--（商业新闻短讯）--临床情报和预测监测公司CLEW今天宣布其FDA批准的、人工智能驱动的智能临床监测平台正式上市。CLEW平台基于专有的机器学习衍生的预测模型和基于规则的最佳实践，为卫生系统提供了对患者恶化风险的早期识别。。

CLEW initially introduced its system of AI-generated prediction models in 2019 to support critical care and telemedicine operations, aiming to enhance patient care in virtual intensive care units (VICUs or Tele-ICUs). Implemented in numerous critical care departments across the United States, including Penn State Health, the system quickly demonstrated its efficacy and CLEW promptly responded to customer demands by expanding its platform to areas such as the emergency department, medical/surgical floors, perioperative suites, and specialty care units..

CLEW最初于2019年推出了人工智能生成的预测模型系统，以支持重症监护和远程医疗操作，旨在增强虚拟重症监护病房（VICUs或远程ICU）的患者护理。该系统在美国各地的许多重症监护部门（包括宾夕法尼亚州立大学卫生部）实施，通过将其平台扩展到急诊科、医疗/外科楼层、围手术期套房和专科护理单位等领域，迅速证明了其有效性，CLEW迅速响应了客户的需求。。

'As we navigate the complexities of modern healthcare, AI-derived systems emerge as a beacon of innovation, transforming our approach to care delivery,” Paul Roscoe, CLEW CEO shared. “When delivered with meticulous regulatory oversight, AI can unlock new possibilities for precision medicine, early detection, and personalized treatments.

CLEW首席执行官保罗·罗斯科（PaulRoscoe）分享道：“当我们驾驭现代医疗保健的复杂性时，人工智能衍生系统成为创新的灯塔，改变了我们的护理方式。”。“在严格的监管监督下，人工智能可以为精准医学、早期发现和个性化治疗开辟新的可能性。

Our commitment to integrating AI-driven prediction models into healthcare reflects our dedication to enhancing patient outcomes, driving efficiencies, and ultimately, saving lives.'.

我们致力于将人工智能驱动的预测模型整合到医疗保健中，这反映了我们致力于提高患者预后，提高效率，最终挽救生命。”。

Equipped with these advanced clinical insights, caregivers can focus on delivering exceptional patient care at the highest level of their licensure. The CLEW system empowers care teams to intervene proactively in identifying high-risk patients up to eight hours before physiological signs and other monitoring systems would indicate.

拥有这些先进的临床见解，护理人员可以专注于以最高许可级别提供出色的患者护理。CLEW系统使护理团队能够在生理体征和其他监测系统显示之前8小时内主动干预识别高危患者。

This leads to lower mortality rates, decreased complications, and fewer readmissions. As a result, proactive and timely care mitigates unforeseen bottlenecks, reduces length of stay and improves overall capacity..

这导致死亡率降低，并发症减少，再入院率降低。因此，积极及时的护理减轻了不可预见的瓶颈，缩短了住院时间并提高了整体能力。。

In addition to CLEW’s robust prediction models, its platform includes built-in, best practice clinical protocols. They are easily customizable, allowing health systems to add their own standard practices for consistent deployment of specific care plans. With its NotifyMe solution, caregivers can receive tailored multi-parameter smart alerts, specifically designed to pinpoint urgent and complex clinical scenarios.

除了CLEW强大的预测模型外，其平台还包括内置的最佳实践临床协议。它们易于定制，允许卫生系统添加自己的标准实践，以一致部署特定的护理计划。通过其NotifyMe解决方案，护理人员可以接收定制的多参数智能警报，专门用于查明紧急和复杂的临床情况。

Clinicians have the flexibility to determine which attributes and clinical criteria are crucial for monitoring and personalize the configuration..

临床医生可以灵活地确定哪些属性和临床标准对于监测和个性化配置至关重要。。

The CLEW platform also includes prediction-driven clinician-centric tools designed to reduce nursing fatigue, including a real-time, priority-driven patient worklist developed in collaboration with nurses at Penn State Health. Since going live with the platform, the critical care team at Penn State has integrated the use of CLEW into their daily workflow..

CLEW平台还包括旨在减少护理疲劳的预测驱动的以临床医生为中心的工具，包括与宾夕法尼亚州立大学健康学院的护士合作开发的实时，优先驱动的患者工作清单。自从该平台上线以来，宾夕法尼亚州立大学的重症监护团队已经将CLEW的使用整合到他们的日常工作流程中。。

A recent peer-reviewed study published in CHEST Journal, notably found that predictions from the CLEW platform were at least five times more accurate than alerts from the leading telemedicine system and generated 50 times fewer alarms than other monitoring systems. For more information about that study, click here..

最近发表在《胸部杂志》上的一项同行评审研究发现，CLEW平台的预测比领先的远程医疗系统的警报准确至少五倍，产生的警报比其他监测系统少50倍。有关该研究的更多信息，请单击此处。。

For more information about the CLEW system, contact the CLEW team.

有关CLEW系统的更多信息，请联系CLEW团队。

About CLEW Medical, Inc.

关于CLEW Medical，Inc。

CLEW offers the first FDA-cleared, class II medical device, AI-based clinical predictive models for critical care as a part of its intelligent clinical surveillance platform. Its ability to offer accurate, predictive insights around patient deterioration allows health systems to optimize patient interventions, decreasing mortality and reducing complications & readmissions.

CLEW作为其智能临床监测平台的一部分，为重症监护提供了第一个FDA批准的II类医疗设备，基于AI的临床预测模型。它能够对患者病情恶化提供准确的预测性见解，使卫生系统能够优化患者干预措施，降低死亡率，减少并发症和再入院率。

Its proprietary models offer an optimal balance of precision and sensitivity, which results in fewer high-risk notifications, reducing alarm fatigue amongst providers and clinicians. For more information, visit clewmed.com..

其专有模型提供了精确度和灵敏度的最佳平衡，从而减少了高风险通知，减少了提供者和临床医生的警报疲劳。有关更多信息，请访问clewmed.com。。